Can A European Approval of Pixantrone Save Cell Therapeutics? (CTIC)
Cell Therapeutics, Inc. (NASDAQ: CTIC) is about as controversial of a biotech stock as there can be. It often traded huge volume around drug approval or study news, and shares ...Read Full Story »








